About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company News
Indegene Ltd
Miscellaneous
BSE Code:
544172
NSE Symbol:
INDGN
P/E :
65.96
ISIN Demat:
INE065X01017
Div & Yield %:
0.36
EPS :
9.34
Book Value:
89.53
Market Cap (Rs. Cr.):
14,846.37
Face Value :
2
Date
Headline
26-Oct-26
Indegene Limited established INDEGENE PORTUGAL, UNIPESSOAL LDA, to serve life sciences clients
15-Oct-26
Mark Dzialga resigns from Indegene board due to Brighton Park Capital’s share sale
08-Oct-26
Indegene Limited’s board approved equity share allotment and policy amendment on October 5
30-Sep-26
Indegene Limited to convene a board meeting October 29 to review financial results
28-Sep-26
Indegene closes trading window for securities ahead of financial results release
10-Sep-26
Indegene's merger of German subsidiaries creates Indegene Healthcare Germany GmbH, projecting €20.1
17-Aug-26
Indegene shareholders appoint Jill Mary De Simone as Independent Director for three years
30-Jul-26
Indegene’s revenue rose 39.7% year-over-year to Rs 10,631 million in Q2 2026
16-Jul-26
Indegene to convene AGM
11-Jul-26
Indegene to hold board meeting
Prev
1
2
3
Next